First Trust Advisors’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-17,708
| Closed | -$264K | – | 2606 |
|
|
2024
Q4 | $264K | Buy |
17,708
+5,337
| +43% | +$79.5K | ﹤0.01% | 2410 |
|
|
2024
Q3 | $189K | Buy |
12,371
+1,796
| +17% | +$27.5K | ﹤0.01% | 2321 |
|
|
2024
Q2 | $161K | Buy |
+10,575
| New | +$161K | ﹤0.01% | 2273 |
|
|
2023
Q2 | – | Sell |
-15,845
| Closed | -$289K | – | 2431 |
|
|
2023
Q1 | $289K | Sell |
15,845
-83,839
| -84% | -$1.53M | ﹤0.01% | 2245 |
|
|
2022
Q4 | $2.06M | Buy |
99,684
+14,924
| +18% | +$309K | ﹤0.01% | 1689 |
|
|
2022
Q3 | $2.22M | Buy |
84,760
+14,110
| +20% | +$369K | ﹤0.01% | 1637 |
|
|
2022
Q2 | $1.79M | Buy |
70,650
+18,761
| +36% | +$475K | ﹤0.01% | 1770 |
|
|
2022
Q1 | $1.64M | Sell |
51,889
-106,838
| -67% | -$3.37M | ﹤0.01% | 1847 |
|
|
2021
Q4 | $6.42M | Buy |
158,727
+138,808
| +697% | +$5.62M | 0.01% | 1237 |
|
|
2021
Q3 | $695K | Sell |
19,919
-84,659
| -81% | -$2.95M | ﹤0.01% | 2169 |
|
|
2021
Q2 | $2.87M | Sell |
104,578
-36,519
| -26% | -$1M | ﹤0.01% | 1668 |
|
|
2021
Q1 | $3.96M | Buy |
141,097
+92,147
| +188% | +$2.59M | ﹤0.01% | 1376 |
|
|
2020
Q4 | $1.27M | Buy |
+48,950
| New | +$1.27M | ﹤0.01% | 1794 |
|